TB Diagnostics Pipeline

Tuberculosis Diagnostics Pipeline Over the past decade, there has been an unprecedented level of interest and activity focused on the development of new tools for TB diagnosis, largely because of the involvement and engagement of agencies such as the Stop TB Partnership’s New Diagnostics Working Group (NDWG), the Foundation for Innovative New Diagnostics (FIND), the Global Laboratory Initiative (GLI), the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR), several industry partners, non-governmental agencies, and national TB programs. Funding agencies such as the Bill & Melinda Gates Foundation, the Global Fund to Fight AIDS, TB and Malaria (GFATM), and UNITAID have provided the much needed resources and impetus to push the new tools agenda, in keeping with the Global Plan to Stop TB. As a consequence, we now have a strong pipeline of improved or new tools for TB diagnosis. The latest global TB diagnostic pipeline is shown below:


For an in-depth review of current status of point-of-care TB diagnostics, see the publication in Discovery Medicine: [Link]

Evaluation pathway (value chain) for new TB diagnostics [Link]

The Journal of Infectious Diseases 2015 – Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects [Link] [supplement]

UNITAID 2014- Tuberculosis Diagnostic Technology and Market Landscape, update[Link]

UNITAID 2013- Tuberculosis Diagnostic Technology and Market Landscape, update [Link]

UNITAID 2012 – Tuberculosis: Diagnostic Technology Landscape [Link]